Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5AP | P20292 | 1/20 | 0.33 |
| ▸ | FEN1 | P39748 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25754003 | 0.80 | MEN1 (0.36) | ALOX5APFEN1MAPTMEN1USP2 | |
| SCHEMBL31359641 | 0.77 | TUBB4A (0.38) | MAPTMEN1KMT2A | |
| SCHEMBL31688065 | 0.69 | MBOAT4 (0.36) | — | |
| SCHEMBL27766509 | 0.67 | ALOX5AP (0.45) | ALOX5APFEN1CA2MAPTMEN1 | |
| SCHEMBL11939075 | 0.67 | ALOX5AP (0.53) | ALOX5APFEN1CA2MAPTMEN1 | |
| SCHEMBL1675886 | 0.67 | ALOX5AP (0.49) | ALOX5APFEN1CA2MAPTMEN1 | |
| SCHEMBL2964912 | 0.66 | ALOX5AP (0.39) | ALOX5APFEN1CA2MAPTLMNA | |
| SCHEMBL1519286 | 0.66 | ALOX5AP (0.40) | ALOX5APFEN1CA2MAPTMEN1 | |
| SCHEMBL29514108 | 0.66 | ALOX5AP (0.40) | ALOX5APFEN1CA2MAPTMEN1 | |
| SCHEMBL26654609 | 0.64 | ALOX5AP (0.39) | ALOX5APFEN1CA2MAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4727935-A1 | TYK2 INHIBITORS AND COMPOSITIONS AND METHODS THEREOF | Lynk Pharmaceuticals Co. Ltd. (CN) | 2026-04-22 | — | — | EP | disclosed |
| WO-2024255886-A1 | TYK2 INHIBITORS AND COMPOSITIONS AND METHODS THEREOF | LYNK PHARMACEUTICALS CO. LTD. (CN) | 2024-12-19 | — | — | WO | disclosed |
| WO-2024254832-A1 | TYK2 INHIBITORS AND COMPOSITIONS AND METHODS THEREOF | LYNK PHARMACEUTICALS CO. LTD. (CN) | 2024-12-19 | — | — | WO | disclosed |